Tue, April 2, 2024

Jessica Fye Maintained (ASND) at Buy with Increased Target to $167 on, Apr 2nd, 2024

Jessica Fye of JP Morgan, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $165 to $167 on, Apr 2nd, 2024.

Jessica has made no other calls on ASND in the last 4 months.



There are 5 other peers that have a rating on ASND. Out of the 5 peers that are also analyzing ASND, 0 agree with Jessica's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Jessica


  • Li Watsek of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $173 on, Monday, April 1st, 2024
  • Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $260 on, Friday, March 15th, 2024
  • Andreas Argyrides of "Wedbush" Maintained at Buy with Increased Target to $225 on, Thursday, February 8th, 2024
  • David Lebowitz of "Citigroup" Maintained at Strong Buy with Increased Target to $182 on, Thursday, February 8th, 2024
  • Kelly Shi of "Jefferies" Initiated at Strong Buy and Held Target at $150 on, Wednesday, December 20th, 2023